Rejean Ruel

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 218(Granted Patents)

Location History:

St. Lazare, CA (2003)
St-Lambert, CA (2005 - 2007)
Quebec, CA (2010)
Lazare, CA (2012)
Saint-Lambert, CA (2004 - 2019)
Montreal, CA (2022 - 2024)

Company Filing History:

12 out of 3,681

Bristol-myers Squibb Compnay

Universitéde Montreal

patents

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12037324 - Biarylmethyl heterocycles (2024-07-16),

2. 11407733 - Biarylmethyl heterocycles (2022-08-09),

3. 10336747 - Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells (2019-07-02),

4. 8273772 - [object Object] (2012-09-25),

5. RE43343 - Inhibitors of histone deacetylase (2012-04-30),

6. 7816382 - [object Object] (2010-10-19),

7. 7700620 - [object Object] (2010-04-20),

8. 7674828 - [object Object] (2010-03-09),

9. 7645778 - [object Object] (2010-01-12),

10. 7388021 - [object Object] (2008-06-17),

11. RE39850 - Inhibitors of histone deacetylase (2007-09-17),

12. 7067525 - Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same (2006-06-27),

13. 6979691 - Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same (2005-12-27),

14. 6969717 - Azaindole kinase inhibitors (2005-11-29),

15. 6713487 - Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same (2004-03-30),

Title: Rejean Ruel: Pioneering Innovator Shaping Tomorrow's World

Introduction: Rejean Ruel, a visionary inventor based in Saint-Lambert, CA, has established himself as a prominent figure in the world of technology with 15 patents to his name. His relentless pursuit of excellence and passion for innovation have garnered him a reputation as a true trailblazer in the field.

Latest Patents: Among his many contributions, two of his latest patents stand out. The first one involves Biarylmethyl heterocycles, which are compounds with tremendous potential as biased agonists or β-Arrestin agonists of the angiotensin II receptor, making them valuable medicaments. The second patent revolves around Pyrimido[4,5-B]indole derivatives, which have shown promise in expanding hematopoietic stem cell populations and treating diseases related to these cells.

Career Highlights: Rejean Ruel's career has seen him leave an indelible mark on some renowned companies in the industry. He has lent his expertise to Bristol-Myers Squibb Company and Methylgene, Inc., where his innovative spirit and dedication to progress have been invaluable assets.

Collaborations: Throughout his career, Rejean Ruel has worked closely with esteemed colleagues such as Carl Thibault and Timothy F Herpin. Their collaborative efforts have led to groundbreaking advancements in the field of technology and healthcare, further solidifying Ruel's status as a visionary inventor.

Conclusion: In conclusion, Rejean Ruel's unwavering commitment to innovation and his exemplary work in the realm of technology paint a picture of a true pioneer. His patents, collaborations, and career highlights all testify to his immense contributions to the world of innovation. As we look towards the future, Ruel's work continues to inspire and shape the evolving landscape of technology and healthcare.

This text is generated by artificial intelligence and may not be accurate.